CRYM Gene Deafness autosomal dominant type 40 Genetic Test
At DNA Labs UAE, we offer the CRYM Gene Deafness autosomal dominant type 40 Genetic Test for individuals who may be experiencing symptoms of hearing loss. This test helps in identifying any mutations or variations in the CRYM gene, which is associated with autosomal dominant type 40 (DFNA40) deafness.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information
Prior to undergoing the CRYM Gene Deafness autosomal dominant type 40 Genetic Test, it is important to provide the clinical history of the patient. This includes information about any symptoms related to CATSPER2 Gene Deafness and male infertility. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by CATSPER2 Gene Deafness and male infertility. This session may also involve genetic testing for the CATSPER2 gene and the CATSPER5 gene.
Test Details
The CRYM gene is specifically associated with autosomal dominant type 40 (DFNA40) deafness. This means that an individual only needs to inherit one copy of the mutated gene from either parent to develop the condition. The CRYM gene can be analyzed using Next-Generation Sequencing (NGS) technology, which allows for the sequencing of multiple genes simultaneously. By analyzing the CRYM gene, any mutations or variations that may be present can be identified.
Genetic testing for DFNA40 is beneficial in confirming a diagnosis for individuals with symptoms of hearing loss. It can also help identify carriers of the mutated gene within families and provide valuable information for genetic counseling and family planning.
It is important to consult with a healthcare professional or genetic counselor to determine if NGS testing for the CRYM gene is appropriate for your specific situation. They can provide more detailed information about the test, its benefits, limitations, and potential implications.
Test Name | CRYM Gene Deafness autosomal dominant type 40 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER5 |
Test Details |
The CRYM gene is associated with deafness, specifically autosomal dominant type 40 (DFNA40). Autosomal dominant means that an individual only needs to inherit one copy of the mutated gene from either parent to develop the condition. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the sequencing of multiple genes simultaneously. In the context of deafness, NGS can be used to analyze the CRYM gene and identify any mutations or variations that may be present. Genetic testing for DFNA40 can help confirm a diagnosis in individuals with symptoms of hearing loss. It can also be useful for identifying carriers of the mutated gene within families, as well as providing information for genetic counseling and family planning. It’s important to consult with a healthcare professional or genetic counselor to determine if NGS testing for the CRYM gene is appropriate for your specific situation. They can provide more detailed information about the test, its benefits, limitations, and potential implications. |